Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Kinin receptor classification.

D Regoli1, D Jukic, C Tousignant

  • 1Department of Pharmacology, Medical School, University of Sherbrooke, Québec, Canada.

Agents and Actions. Supplements
|January 1, 1992
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Neuropeptide S is a stimulatory anxiolytic agent: a behavioural study in mice.

British journal of pharmacology·2008
Same author

Involvement of kinin B1 receptor and oxidative stress in sensory abnormalities and arterial hypertension in an experimental rat model of insulin resistance.

Neuropeptides·2007
Same author

Tryptophan replacement in the nociceptin/orphanin FQ receptor ligand Ac-RYYRWK-NH2.

The journal of peptide research : official journal of the American Peptide Society·2005
Same author

Antidepressant-like effects of the nociceptin/orphanin FQ receptor antagonist UFP-101: new evidence from rats and mice.

Naunyn-Schmiedeberg's archives of pharmacology·2004
Same author

Nonpeptide/peptide chimeric ligands for the nociceptin/orphanin FQ receptor: design, synthesis and in vitro pharmacological activity.

The journal of peptide research : official journal of the American Peptide Society·2004
Same author

Blockade of nociceptin/orphanin FQ-NOP receptor signalling produces antidepressant-like effects: pharmacological and genetic evidences from the mouse forced swimming test.

The European journal of neuroscience·2003

Kinin agonists and antagonists exhibit varied affinities across different smooth muscles, suggesting distinct B1 and B2 receptor subtypes. Histamine release from mast cells by kinins may not involve specific receptors.

Area of Science:

  • Pharmacology and Physiology
  • Kinin-receptor interactions
  • Smooth muscle contraction

Background:

  • Kinin peptides play crucial roles in physiological processes, including blood pressure regulation and inflammation.
  • Understanding kinin receptor subtypes and their pharmacology is essential for developing targeted therapeutics.
  • Previous studies have identified various kinin receptor subtypes, but their precise characterization remains ongoing.

Purpose of the Study:

  • To characterize the apparent affinities of kinin agonists and antagonists on isolated smooth muscles.
  • To investigate the ability of kinin compounds to induce histamine release from rat mastocytes.
  • To elucidate the functional sites and potential receptor subtypes involved in kinin activity.

Main Methods:

Related Experiment Videos

  • Determination of apparent affinities (pD2 and pA2 values) of kinin agonists and antagonists on rabbit jugular vein (Rb.J.V.), rabbit aorta (Rb.A.), and guinea pig ileum (G.P.I.).
  • Evaluation of kinin compounds for their capacity to induce histamine release from rat mastocytes.
  • Utilized specific kinin analogs and receptor antagonists to probe receptor interactions.

    • Main Results:

    • Kininase I metabolites acted as agonists on Rb.A. (B1) but were inactive on Rb.J.V. and G.P.I. (B2 preparations).
    • Specific kinin analogs ([Tyr(Me)8]-BK, [Hyp3,Tyr(Me)8]-BK, [Hyp3]-BK, [Aib7]-BK) displayed differential affinities across the tested tissues, indicating receptor subtype variations.
    • B2 receptor antagonists differentially affected kinin-induced contractions, and all tested compounds were potent in inducing histamine release from mastocytes, although a clear receptor mechanism was not identified.

    Conclusions:

    • Kinin activity is mediated through at least four functional sites: B1 (Rb.A.), B2A (Rb.J.V.), B2B (G.P.I.), and BH.
    • The B2A and B2B receptor subtypes may represent species-specific variations of the B2 receptor.
    • Histamine release from rat mast cells by kinins might occur via a non-receptor-mediated pathway.